 |
 |
|
|
|
Manufacturer:
Merck Frosst
|
|
Description:
Fosavance is used once a week for the treatment of osteoporosis in postmenopausal women and in men with osteoporosis. Fosavance is the only biphosphonate medication available that delivers the benefits of a weekly dose of vitamin D, a nutrient essential for healthy bones.
|
|
Ingredients:
Fosavance contains 70 mg alendronate (bisfosfonat) and 70 µg (2800 IU) vitamin D3.
|
|
|

There are currently no items in the cart.
|
|



|
|
Customers' medical and financial information are only used to fulfill orders and not shared with third parties without your prior consent.
|